122 related articles for article (PubMed ID: 33498795)
1. Synthesis and Optimization of Mesoporous Silica Nanoparticles for Ruthenium Polypyridyl Drug Delivery.
Harun SN; Ahmad H; Lim HN; Chia SL; Gill MR
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33498795
[TBL] [Abstract][Full Text] [Related]
2. Synergy of ruthenium metallo-intercalator, [Ru(dppz)
Yusoh NA; Chia SL; Saad N; Ahmad H; Gill MR
Sci Rep; 2023 Jan; 13(1):1456. PubMed ID: 36702871
[TBL] [Abstract][Full Text] [Related]
3. Optimization of Mesoporous Silica Nanoparticles through Statistical Design of Experiment and the Application for the Anticancer Drug.
Kim MK; Ki DH; Na YG; Lee HS; Baek JS; Lee JY; Lee HK; Cho CW
Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33572523
[TBL] [Abstract][Full Text] [Related]
4. Polydiacetylene/lipid-coated red-emissive silica nanorods for the sustained release and ameliorated anticancer efficacy of a Ru(arene) complex bearing piperlongumine natural product.
Ishaniya W; Sumithaa C; Subramani M; Karanath-Anilkumar A; Munuswamy-Ramanujam G; Madan Kumar A; Rajendran S; Ganeshpandian M
Dalton Trans; 2024 Jan; 53(4):1616-1629. PubMed ID: 38165714
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of new ruthenium polypyridyl complexes with potent antitumor activity in vitro.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Sep; 220():117132. PubMed ID: 31146211
[TBL] [Abstract][Full Text] [Related]
6. pH-Responsive Release of Ruthenium Metallotherapeutics from Mesoporous Silica-Based Nanocarriers.
Mladenović M; Morgan I; Ilić N; Saoud M; Pergal MV; Kaluđerović GN; Knežević NŽ
Pharmaceutics; 2021 Mar; 13(4):. PubMed ID: 33800647
[TBL] [Abstract][Full Text] [Related]
7. Ruthenium(II) Polypyridyl Complexes as FRET Donors: Structure- and Sequence-Selective DNA-Binding and Anticancer Properties.
Elgar CE; Yusoh NA; Tiley PR; Kolozsvári N; Bennett LG; Gamble A; Péan EV; Davies ML; Staples CJ; Ahmad H; Gill MR
J Am Chem Soc; 2023 Jan; 145(2):1236-1246. PubMed ID: 36607895
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
[TBL] [Abstract][Full Text] [Related]
9. Critical Overview of the Use of Ru(II) Polypyridyl Complexes as Photosensitizers in One-Photon and Two-Photon Photodynamic Therapy.
Heinemann F; Karges J; Gasser G
Acc Chem Res; 2017 Nov; 50(11):2727-2736. PubMed ID: 29058879
[TBL] [Abstract][Full Text] [Related]
10. New ruthenium polypyridyl complexes functionalized with fluorine atom or furan: Synthesis, DNA-binding, cytotoxicity and antitumor mechanism studies.
Jiang GB; Zhang WY; He M; Gu YY; Bai L; Wang YJ; Yi QY; Du F
Spectrochim Acta A Mol Biomol Spectrosc; 2020 Feb; 227():117534. PubMed ID: 31685424
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, DNA-binding affinity, cytotoxicity, apoptosis, and cell cycle arrest of Ru(II) polypyridyl complexes.
Venkat Reddy P; Reddy MR; Avudoddi S; Praveen Kumar Y; Nagamani C; Deepika N; Nagasuryaprasad K; Singh SS; Satyanarayana S
Anal Biochem; 2015 Sep; 485():49-58. PubMed ID: 26079705
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and anticancer effect of the ruthenium (II) polypyridyl complexes on HepG2 cells.
Wan D; Lai SH; Yang HH; Tang B; Zhang C; Yin H; Zeng CC; Liu YJ
J Photochem Photobiol B; 2016 Dec; 165():246-255. PubMed ID: 27816647
[TBL] [Abstract][Full Text] [Related]
13. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
Yan Y; Fu J; Wang T; Lu X
Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
[TBL] [Abstract][Full Text] [Related]
14. Modified mesoporous silica nanoparticles for enhancing oral bioavailability and antihypertensive activity of poorly water soluble valsartan.
Biswas N
Eur J Pharm Sci; 2017 Mar; 99():152-160. PubMed ID: 27993684
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, antitumor activity and structure-activity relationships of a series of Ru(II) complexes.
Liu J; Zheng W; Shi S; Tan C; Chen J; Zheng K; Ji L
J Inorg Biochem; 2008 Feb; 102(2):193-202. PubMed ID: 17825915
[TBL] [Abstract][Full Text] [Related]
16. Visible Light Photocleavable Ruthenium-Based Molecular Gates to Reversibly Control Release from Mesoporous Silica Nanoparticles.
Salinas Y; Brüggemann O; Monkowius U; Teasdale I
Nanomaterials (Basel); 2020 May; 10(6):. PubMed ID: 32481603
[TBL] [Abstract][Full Text] [Related]
17. Novel polypyridyl ruthenium complexes acting as high affinity DNA intercalators, potent transcription inhibitors and antitumor reagents.
Ma GL; Bi XD; Gao F; Feng Z; Zhao DC; Lin FJ; Yan R; Liu D; Liu P; Chen J; Zhang H
J Inorg Biochem; 2018 Aug; 185():1-9. PubMed ID: 29730231
[TBL] [Abstract][Full Text] [Related]
18. DNA interaction of ruthenium(ii) complexes with imidazo[4,5-f][1,10]phenanthroline derivatives.
Yu B; Rees TW; Liang J; Jin C; Chen Y; Ji L; Chao H
Dalton Trans; 2019 Mar; 48(12):3914-3921. PubMed ID: 30816388
[TBL] [Abstract][Full Text] [Related]
19. Ruthenium polypyridyl complexes as inducer of ROS-mediated apoptosis in cancer cells by targeting thioredoxin reductase.
Luo Z; Yu L; Yang F; Zhao Z; Yu B; Lai H; Wong KH; Ngai SM; Zheng W; Chen T
Metallomics; 2014 Aug; 6(8):1480-90. PubMed ID: 24823440
[TBL] [Abstract][Full Text] [Related]
20. Stimuli-responsive functionalized mesoporous silica nanoparticles for drug release in response to various biological stimuli.
Chen X; Cheng X; Soeriyadi AH; Sagnella SM; Lu X; Scott JA; Lowe SB; Kavallaris M; Gooding JJ
Biomater Sci; 2014 Jan; 2(1):121-130. PubMed ID: 32481814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
